The GÖTEBORG prostate cancer screening 2 trial: a prospective, randomised, population-based prostate cancer screening trial with prostate-specific antigen testing followed by magnetic resonance imaging of the prostate-Reference-Cited by-同舟云学术

The GÖTEBORG prostate cancer screening 2 trial: a prospective, randomised, population-based prostate cancer screening trial with prostate-specific antigen testing followed by magnetic resonance imaging of the prostate

Published:2021-02-22 Issue:2 Volume:55 Page:116-124
ISSN:2168-1805
Container-title:Scandinavian Journal of Urology
language:en
Short-container-title:Scandinavian Journal of Urology

Author:

Kohestani Kimia¹²^ORCID,Månsson Marianne¹^ORCID,Arnsrud Godtman Rebecka¹²^ORCID,Stranne Johan¹²^ORCID,Wallström Jonas³⁴^ORCID,Carlsson Sigrid¹⁵^ORCID,Hellström Mikael³⁴^ORCID,Hugosson Jonas¹²

Affiliation:

1. Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

2. Department of Urology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden

3. Department of Radiology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

4. Department of Radiology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden

5. Departments of Surgery (Urology Service) and Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Funder

Swedish Cancer Society

Swedish government and the county councils

ALF-agreement

Regional Cancer Center West

Swedish Research Council

National Institutes of Health/National Cancer Institute

Publisher

Informa UK Limited

Subject

Urology,Nephrology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21681805.2021.1881612

Reference32 articles.

1. Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer

2. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy ≥72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1–T2 prostate cancer

3. Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate

4. Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

5. Prostate Cancer–Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Screening: Theory and Applications;International Encyclopedia of Public Health;2025

2. Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening Trial;European Urology;2024-09

3. How a population-based cohort of men estimate lifetime risk of prostate cancer in a survey before entering a prostate cancer screening trial in Sweden?;BMJ Open;2024-08

4. Prostate Cancers in the Prostate-specific Antigen Interval of 1.8–3 ng/ml: Results from the Göteborg-2 Prostate Cancer Screening Trial;European Urology;2024-08

5. Comparing the Performance of Digital Rectal Examination and Prostate-specific Antigen as a Screening Test for Prostate Cancer: A Systematic Review and Meta-analysis;European Urology Oncology;2024-08